Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,249
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Franklin TN, Nashville TN, Corbin KY, Paducah KY,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Location: Brentwood TN, Nashville TN, Atlanta GA, Indianapolis IN,
Sponsor: GRAIL, Inc.
Sex: All
Age: 50+
Code: NCT05673018
Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
for
HIV Infections
Location: Nashville TN, Philadelphia PA, Boston MA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT06665646
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Hermitage TN, Anniston AL, Homewood AL, St Louis MO,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase2, Recruiting
Applied Clinical Neuroscience and Its Effect on Self-reported Stress and Other Physiological Markers
for
Stress
Location: Nashville TN
Sponsor: Dylan Saulsbery
Sex: All
Age: 18+
Code: NCT06358560
Recruiting
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
for
Head and Neck Squamous Cell Carcinoma
Location: Nashville TN, Chattanooga TN, Louisville KY, Atlanta GA,
Sponsor: Merus B.V.
Sex: All
Age: 18+
Code: NCT06525220
Phase3, Recruiting
Vanderbilt Integrated Community TMS for Opioid Recovery
for
Opiod Use Disorder
Location: Brentwood TN, Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 65
Code: NCT07457489
Recruiting
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
for
Long COVID
Location: Brentwood TN
Sponsor: MaxWell Clinic, PLC
Sex: All
Age: 18+
Code: NCT06311435
Recruiting
Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients
for
Alzheimer Disease
Location: Brentwood TN
Sponsor: MaxWell Clinic, PLC
Sex: All
Age: 18+
Code: NCT06079827
Recruiting
Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor
for
Intradialytic Hypotension
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 70+
Code: NCT05834777
Phase3, Recruiting
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
for
KRAS P.G12C
Location: Nashville TN, Detroit MI, Sarasota FL, Houston TX,
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05410145
Phase1, Phase2, Recruiting
Impact of Pelvic Pain Podcast
for
Chronic Pelvic Pain, Endometriosis
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: Female
Age: 18+
Code: NCT07568834
Recruiting
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Nashville TN, Lexington KY, St Louis MO, Creve Coeur MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase2, Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus OH,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: Nashville TN, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase1, Recruiting
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Nashville TN, Columbus OH, New York NY, Mineola NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05422794
Phase1, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Nashville TN, Atlanta GA, Carterville IL,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase3, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer